Search Results
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Min Ren in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Qianlan Yao in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Longlong Bao in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Zhiting Wang in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Ran Wei in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Qianming Bai in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Bo Ping in
Google Scholar
PubMed
Department of Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Cai Chang in
Google Scholar
PubMed
Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Yu Wang in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Xiaoyan Zhou in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Xiaoli Zhu in
Google Scholar
PubMed
clinical diagnosis of indeterminate thyroid nodules and personalized treatment. Published data regarding the value of the ThyroSeq v2 NGS assay for the diagnosis of indeterminate nodules show a high negative predictive value (NPV, 91–96%) and relatively low
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Search for other papers by Clara Lazzaretti in
Google Scholar
PubMed
Search for other papers by Elia Paradiso in
Google Scholar
PubMed
Search for other papers by Federico Nuzzo in
Google Scholar
PubMed
Search for other papers by Martina Sitti in
Google Scholar
PubMed
Search for other papers by Frank Tüttelmann in
Google Scholar
PubMed
Search for other papers by Gabriele Moretti in
Google Scholar
PubMed
Search for other papers by Roberto Silvestri in
Google Scholar
PubMed
Search for other papers by Federica Gemignani in
Google Scholar
PubMed
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
Search for other papers by Asta Försti in
Google Scholar
PubMed
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Kari Hemminki in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Cristina Romei in
Google Scholar
PubMed
Search for other papers by Eric Adriano Zizzi in
Google Scholar
PubMed
Search for other papers by Marco Agostino Deriu in
Google Scholar
PubMed
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria, Modena, Italy
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
Search for other papers by Stefano Landi in
Google Scholar
PubMed
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Livio Casarini in
Google Scholar
PubMed
-therapeutic procedures should aim to avoid both delayed diagnosis and overmedication. To date, the management of thyroid nodules suspected to be DTC is mainly guided by the sonographic risk pattern and the coexistence of other risk factors ( 3 ). Genetics could play a